Company Description
Synta isn't a foreign roly-poly elf who brings gifts to tots in the wintertime, but it might be able to bring healthier times to those suffering...
Key Synta Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): SNTA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.7 |
| 2007 Employees | 146 |
Latest Synta Pharmaceuticals Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Synta Pharmaceuticals's competition across multiple industries
Top Synta Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Synta Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Keith R. Gollust | Network | E-mail |
| President, CEO, and Director | Safi R. Bahcall | Network | E-mail |
| VP Investor Relations and Corporate Communications | Robert (Rob) Kloppenburg | Network | E-mail |
More Synta Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Synta Pharmaceuticals News
- PYRAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY [European Patents] (01 Jul 2008 13:08:00 EDT)
- TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY [European Patents] (17 Jun 2008 12:16:00 EDT)
- FirstAlert: 1-2:30 P.M. Investrend / Bestcalls [InvesTrend] (12 Jun 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.